T3 Defense Inc. (DFNS) - Q1 2026 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended March 31, 2026. T3 Defense Inc. (formerly Nukkleus Inc.) has transformed from a financial technology provider into a strategic acquirer and operator of aerospace and defense (A&D) businesses. The company focuses on Tier 2 and Tier 3 suppliers in the defense, aerospace, and advanced manufacturing sectors across the U.S., Israel, and Europe. As of March 31, 2026, the company reported 60,270,525 shares of common stock outstanding.
Key Financial Metrics
| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Revenue | $3.65 million | $0 |
| Gross Profit | $0.37 million | $0 |
| Operating Loss | ($3.81 million) | ($1.51 million) |
| Net Loss | ($26.35 million) | $102.96 million (Income) |
| Net Loss Per Share (Diluted) | ($1.14) | $18.15 (Income) |
| Cash and Cash Equivalents | $7.36 million | $3.95 million (Beginning) |
| Total Assets | $315.49 million | $202.39 million |
| Total Liabilities | $98.40 million | $45.19 million |
| Stockholders' Equity | $42.52 million | ($15.58 million) |
Working Capital: The company reported negative working capital of approximately $69 million. However, $56 million of this consists of stock purchase warrant liabilities that do not require cash settlement.
Material Changes vs. Prior Period
- Revenue Generation: The company generated $3.65 million in revenue in Q1 2026, compared to zero in Q1 2025, driven by new acquisitions (Rimon, ITS, Tiltan).
- Net Income Volatility: Net loss of $26.35 million in Q1 2026 contrasts sharply with net income of $102.96 million in Q1 2025. The prior year income was primarily driven by a $104.28 million gain from the change in fair value of stock purchase warrant liabilities. In Q1 2026, this item resulted in a $26.64 million loss.
- Acquisition Activity: Significant balance sheet growth due to acquisitions of Star 26 Capital Inc. (Jan 2026), Nimbus Drones (Jan 2026), and a 51% stake in ITS (Feb 2026). Goodwill increased from $7.69 million to $100.15 million.
- Financing: The company raised $10 million in a private placement of Series B Preferred Stock and warrants in February 2026. Proceeds were fully allocated to warrant liabilities due to fair value accounting, resulting in a $15.4 million day-one financing expense.
Guidance, Outlook, Risks, and Unusual Items
- Going Concern: Management has alleviated substantial doubt regarding the company's ability to continue as a going concern. Plans include utilizing existing cash ($7.4 million), an active Equity Line of Credit (ELOC) with Esousa Holdings, LLC, and cash-positive subsidiaries (Rimon, Nimbus).
- Geopolitical Risk: Operations are heavily concentrated in Israel. While a ceasefire was reached in April 2026, the security situation remains fragile. Escalation in February 2026 between Israel and Iran caused regional instability, though large-scale operations had subsided by quarter-end.
- Nasdaq Compliance: On May 5, 2026, the company received notice of non-compliance with Nasdaq's minimum bid price requirement ($1.00). The company has 180 days to regain compliance or risk delisting. A reverse stock split is a potential remedy.
- Legal Proceedings: A lawsuit was filed by Kingswood Capital Partners, LLC alleging an unpaid investment banking success fee. The company denies the allegations.
- Subsequent Events:
- Debt Conversion: In April 2026, $2.14 million in notes to the CEO were converted into 4.17 million shares of common stock.
- Asset Sale: Water IO (subsidiary) sold Zorro Net Ltd. to BiomX Inc. for 1.3 million BiomX shares and a $1.25 million promissory note.
- Share Exchange: In May 2026, T3 exchanged 6 million shares for 475,492 shares of VisionWave Holdings, Inc.
Investor Verification Checklist
- Warrant Liability Valuation: Verify the assumptions (volatility, term) used to value the $56.2 million in warrant liabilities, as changes in fair value significantly impact net income.
- Nasdaq Compliance Plan: Confirm the specific steps and timeline for regaining the $1.00 minimum bid price to avoid delisting.
- Acquisition Integration: Assess the revenue contribution and profitability of the new subsidiaries (Star 26, Nimbus, ITS) to determine if they can offset the high operating expenses.
- Geopolitical Exposure: Evaluate the specific operational disruptions in Israel and the contingency plans for supply chain or personnel risks.
- Liquidity Runway: Confirm the drawdown capacity and terms of the ELOC with Esousa Holdings to ensure sufficient funding for the next 12 months.